AN OPPORTUNITY FOR PRIMARY CARE

Similar documents
National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Use of disease registries for benefitrisk evaluation of medicines: A regulatory perspective. DIA Europe April Basel, Switzerland

European Patients Academy on Therapeutic Innovation

European Patients Academy (EUPATI) Update

European Reference Networks (ERN) Guide for patient advocates

EUPATI PROJECT: EXECUTIVE SUMMARY

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

Pharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA

Developing a European Registry for Rare Anaemias

Patient Registries Initiative Background, Achievements, Next steps

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

Lessons from the EMA Patient Registries Initiative

Council of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Confronting the Challenges of Rare Disease:

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

4. Multi Stakeholder: Late & Early Dialogue

Meeting report series. Report of the 16th Therapies Scientific Committee Meeting

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

High Level Pharmaceutical Forum

Policies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe

Horizon Health

Retrospective Chart Review Studies

A multi-ethnic multi-national approach to ethical approval of clinical trials involving Thalassaemia patients: the DEEP lesson. Prof.

116 Help Lines for Rare Diseases

Minutes of EMA Human Scientific Committees Working Party with Patients and Consumers Organisations (PCWP) meeting with all eligible organisations

The German Institute of Medical Documentation and Information

ERN Assessment Manual for Applicants

x x x x x x x x x x x x Good Medical Practice domains WPBA CSA AKT Curriculum Areas of Competence CbD COT CEX DOPs PSQ MSF CSR

Compassionate Use Systems in the EU How to improve for early access to patients

Executive Report to the European Commission on newborn screening in the European Union

Resource on the State of the Art of Rare Disease Activities in Europe

ehealth Ireland Ecosystem members of the ECHAlliance International Ecosystem Network

Do European Reference Networks fit national structures? A German perspective

2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Denmark Report

Meeting report series. Report of the 17th Therapies Scientific Committee Meeting

Value Added Medicines Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

Targeted technology and data management solutions for observational studies

Rare Disease Registries

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

Newborn Screening Programmes in the United Kingdom

Cross-Border Enrollment of Rare Disease Patients

WORKING TOGETHER WITH PATIENT GROUPS

SCHEDULE 2 THE SERVICES

European Haemophilia Consortium

Collaborating with patients: learning from psoriasis and other diseases

SMA Clinical Care Center Network / Clinical Data Registry & Clinical Trials Site Readiness for SMA. March 21, 2018

EARLY ACCESS IN BELGIUM: STATUS UPDATE. Veerle Kempeneers & Rudy De Cock - Pfizer Kristel De Gauquier pharma.be

Patient information and how patient advocacy can strengthen education and best practice

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

Improving Infection Control and Hospital Hygiene in Europe: Professional Networks and European Programs. Silvio Brusaferro

NoRo - a reference centre for RD

Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force

What is EUPATI? The EUPATI project receives support from the European Union (IMI JU) and EFPIA companies

REFLECTION PROCESS on CHRONIC DISEASES INTERIM REPORT

Medicare s Impact on Cardiology Drugs and Devices During Clinical Research

NICE s Highly Specialised Technologies (HST) evaluation committee

Council of the European Union Brussels, 24 February 2015 (OR. en)

VSOP, Lupus Netherlands

CALL FICHE 1 SCIENCE IN SOCIETY 2009

COPD Management in the community

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

National Strategies & Action for Rare Diseases in Europe

Meaningful Patient Advocacy

The Riga Roadmap Investing in Health and Wellbeing for All

The following passage wants to illustrate the insufficiencies in CF care the patients, their families and care giver struggle with:

Core competencies* for undergraduate students in clinical associate, dentistry and medical teaching and learning programmes in South Africa

What is Social Networking?

What is Social Networking?

National Standards Assessment Program. Quality Report

TELEHEALTH INDEX: 2015 PHYSICIAN SURVEY

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Using Evidence to Support the Business Case the route to adoption

HMSA Physical and Occupational Therapy Utilization Management Guide

Big data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament

Work plan for GCP Inspectors Working Group for 2018

The Pharmaceutical Risk Assessment Committee (PRAC) of the EMA

The presenter has owns Kelly Willenberg, LLC in relation to this educational activity.

THE EUROPEAN DEFINITION OF GENERAL PRACTICE / FAMILY MEDICINE

HTA and Patient Registries. Fedele (Duccio) Bonifazi

INTERREG ATLANTIC AREA PROGRAMME CITIZENS SUMMARY

Real World Evidence in Europe

***I DRAFT REPORT. EN United in diversity EN. European Parliament 2018/0018(COD)

Document: Report on the work of the High Level Group in 2006

Horizon 2020 calls on. Health, Demographic change and Well-being

Part C - To be completed by the Occupational Health Doctor

Rt hon Jeremy Hunt MP Secretary of State for Health and Social Care. Letter by to Dear Jeremy

Sports Medicine Elective PL-1 Residents

V European Conference On Survivors and Chronic Cancer Patients The Nursing Role in Models

Leadership, Teamwork and Patient Safety

The new inspection process for End of Life Care. Dr Stephen Richards GP Advisor - London Care Quality Commission

OUTPATIENT LIVER INTRODUCTION:

Are you participating in any other research studies? Yes No

Acting Together: How to continue to provide high quality and universally accessible health services in a financially sustainable way in Europe.

Digitalisation enhancing voice of elderly

Making the most of patient registries

Consultation: Transformation Health and Care in the Digital Single

Our care service. The support we offer to children with life-limiting conditions, and their families

ehealth and patient empowerment: A patient perspective

Inpatient Psychiatric Services for Under Age 21 Arkansas Medicaid Regulations and Documentation

Transcription:

RARE DISEASES AN OPPORTUNITY FOR PRIMARY CARE Gerard Nguyen Primary Care, Cabinet Marcel Monny Lobe, Soisy sous Montmorency France Hopital Avicenne APHP Rett Syndrome Europe, AFSR, HUFERDIS (Hungary)

RARE & MANY The RD Community success story The Lessons Learned The State of the Art New Landscape of Primary Care Practice Facing New Challenges

UNMET NEEDS Problems listed by patients (EURORDIS) Lack of access to correct diagnosis Lack of information Lack of scientific knowledge Social consequences Lack of appropriate quality of care Inequities in treatment and care High cost of existing drugs and care

DIAGNOSIS PROCESS Fabry disease: : average delay of 15 y after clinical presentation EURORDIS survey : 25 % of respondents (n=5980), 5 to 30 y from onset of symptoms and diagnosis confirmation, 40% reported an initial wrong diagnosis

THE FINANCIAL BURDEN

RARE & MANY Rare 1/1200 in the US 1/2000 in the EU 1/2500 in Japan Many 7000 diseases 8% of the population, 25 M in the US 6-8% and 30 M in Europe

RARE & MANY = COLLABORATION Respond to patients expectations Mobilisation of critical mass of expertise and resources Avoid overlap Deliver new cures and diagnoses Bridging gaps Collective intelligence Gathering all stakeholders***

RESEARCH ISSUES

EU FUNDING

WORLDWIDE COLLABORATION

E RARE 3: COLLABORATION INFRASTRUCTURES

EU RD ACTIVITY

ORPHAN DRUG: STATUS DESIGNATION

OD POSITIVE OPINION BY THERAPEUTIC AREA

PATIENT TRAINING

Web: www.patientsacademy.eu Twitter: @eupatients as well as:

NATIONAL RD PLANS

SOCIAL HEALTH EURORDIS Survey

FRANCE RD NATIONAL PLAN (1) C. Nourissier

FRANCE RD NATIONAL PLAN (2) C. Nourissier

FRANCE RD NATIONAL PLAN (2) C. Nourissier

RARE & MANY = COLLABORATION Respond to patients expectations Mobilisation of critical mass of expertise and resources Avoid overlap Deliver new cures and diagnoses Bridging gaps Collective intelligence Gathering all stakeholders*** PRIMARY CARE ACTORS?

NEW LANDSCAPE OF PRIMARY CARE Re-appraisal Role and Responsability Rebuilding the ecosystem Re-positioning Front Line Go-between actor

PRIMARY CARE Front line Management of undifferentiated problems in unselected patients Management of common problems in common patients And extraordinary, complex cases in ordinary practice Narrative Medicine Centered approach Story telling, anecdotes Diagnosis delivery, announcement Decision making in Real life

PRIMARY CARE 12,7% patients with RD The first to identify the problem in 89% To establish the definitive diagnosis in 54% To provide acute care for the problem in 56% and continuing care in 76% ca re for the patients through their final illnesses in 17%... sought consultation from specialists for 85% W Philips, 2004

DIAGNOSIS PROCESS IN PRIMARY CARE I suspect something wrong. And consult the literature: 12.3% And consult experts to help me: 23.1% And refer to experts to make the diagnosis: 64.6%

ASPECTS OF DIAGNOSIS Atypical presentation Non specific symptoms Co-morbidity +++ Very rare conditions Life threatening Family burden first time features something wrong

PRIMARY CARE ISSUES PC HCP Child Family

RD PRIMARY CARE ECOSYSTEM Center of Expertise Refernce Networks Helplines POs Research projects, CT, Registries PC HCP Child Family Siblings Social services Respite solutions

LESSONS LEARNED: NEW CHALLENGES Patient social media, communities on line Telemedicine, e patient, patient 2.0 Advanced Therapy, Gene therapy process Consequences of fast track drug development Personalised Medicine Big data

PERSPECTIVES THE CHILDREN WORLD

MULTIMEDIA PATIENT SOCIAL NETWORKS. What is Social Media? social media collaboration, interaction and sharing web 2.0 video some popular tools are blogs, wikis, Twitter and?

New practices: information search Orphanet Eucerd Irdirc Horizon 2020 EMA PDCO, COMP EudraCT Eurordis I have a RD X With a mutation XYZ Under a OD - MA under control -PMS -RMP - Registries (Drug and Disease) -ATU -Off label - FB : shortage soon - Care protocol - Biomarker follow - Reimbursement protocol - Informed consent - Data privacy - Transborder directive - Reference network

RD AN OPPORTUNITY FOR PRIMARY CARE Lessons learned from RD Community activism and activities How to manage complex situations How to step in the future How to move from disease centered to patient centered care How to innovate (tools, practices, drug development and drug access, pricing, HTA ) How to implement Quality of practice (COI) Disease Patien t HCP : Gardianship of Patient Centered Care & Ethics of Care

CONCLUSION: A CALL TO ACTION An empowerment program Training: RD intensive course Research in primary care Becoming active stakeholders in CE, Refernce Networks Implementing information platform Taking part in registries, surveys Participating in calls for experts and calls for projects To advocate Added value of care For inclusion of primary care in research program (Horizon 2020) For new organisation of primary care integrating case manager